Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe revision label at the bottom of the page changes from Revision: v3.5.3 to Revision: v3.5.4, indicating a minor update to the page’s version history rather than updates to study content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows an updated revision label (v3.5.3 instead of v3.5.2), indicating a minor site/package update rather than a change to the underlying study information.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedVersion history updated with new entries for 2026-03-17, 2026-03, 2026-02-25, 2026-02 and Revision: v3.5.0. Older entries such as 2025-03-19, 2026-09, 2025-03-17, 2025-03 and Revision: v3.4.3 were removed.SummaryDifference0.3%

- Check85 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check113 days agoChange DetectedAdded Revision: v3.4.2 banner; removed the previous government-funding operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.